Epam (EPAM) Q1 Earnings: How Key Metrics Evaluate to Wall Road Estimates

Date:

For the quarter ended March 2024, Epam (EPAM) reported income of $1.17 billion, down 3.8% over the identical interval final 12 months. EPS got here in at $3.06, in comparison with $2.47 within the year-ago quarter.

The reported income compares to the Zacks Consensus Estimate of $1.16 billion, representing a shock of +0.30%. The corporate delivered an EPS shock of +31.90%, with the consensus EPS estimate being $2.32.

Whereas buyers carefully watch year-over-year modifications in headline numbers — income and earnings — and the way they evaluate to Wall Road expectations to find out their subsequent plan of action, some key metrics all the time present a greater perception into an organization’s underlying efficiency.

As these metrics affect top- and bottom-line efficiency, evaluating them to the year-ago numbers and what analysts estimated helps buyers mission a inventory’s value efficiency extra precisely.

Right here is how Epam carried out within the simply reported quarter by way of the metrics most generally monitored and projected by Wall Road analysts:

  • Revenues by Buyer Location- Americas: $692.92 million in comparison with the $688.07 million common estimate primarily based on two analysts.
  • Revenues by Buyer Location- APAC: $23.30 million versus the two-analyst common estimate of $24.26 million.
  • Revenues by Buyer Location- EMEA: $449.25 million versus $440.61 million estimated by two analysts on common.
  • Revenues by Contract Sort- Time-and-material: $981.53 million versus $1 billion estimated by two analysts on common.
  • Revenues by Contract Sort- Fastened-price: $176.32 million in comparison with the $147.34 million common estimate primarily based on two analysts.
  • Revenues by Contract Sort- Licensing: $7.62 million versus the two-analyst common estimate of $9.39 million.
  • Revenues by Business Verticals- Journey & Shopper: $259.13 million versus $262.45 million estimated by two analysts on common.
  • Revenues by Business Verticals- Rising Verticals: $179.64 million versus $171.83 million estimated by two analysts on common.
  • Revenues by Business Verticals- Enterprise Info & Media: $170.32 million versus the two-analyst common estimate of $184.51 million.
  • Revenues by Business Verticals- Software program & Hello-Tech: $173.43 million versus the two-analyst common estimate of $176.35 million.
  • Revenues by Business Verticals- Life Sciences & Healthcare: $140.21 million versus the two-analyst common estimate of $117.09 million.
  • Revenues by Business Verticals- Monetary Providers: $242.74 million versus $249.34 million estimated by two analysts on common.

View all Key Company Metrics for Epam here>>>

Shares of Epam have returned -6.6% over the previous month versus the Zacks S&P 500 composite’s -0.3% change. The inventory presently has a Zacks Rank #4 (Promote), indicating that it might underperform the broader market within the close to time period.

Zacks Names “Single Greatest Decide to Double”

From 1000’s of shares, 5 Zacks specialists every have chosen their favourite to skyrocket +100% or extra in months to return. From these 5, Director of Analysis Sheraz Mian hand-picks one to have probably the most explosive upside of all.

It’s an American AI firm that’s driving low proper now, nevertheless it has rounded up purchasers like BMW, GE, Dell Pc, and Bosch. It has prospects for not simply doubling however quadrupling within the 12 months to return. In fact, all our picks aren’t winners however this one might far surpass earlier Zacks’ Shares Set to Double like Boston Beer Firm which shot up +143.0% in little greater than 9 months and NVIDIA which boomed +175.9% in a single 12 months.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

EPAM Systems, Inc. (EPAM) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the writer and don’t essentially mirror these of Nasdaq, Inc.

Share post:

Subscribe

Popular

More like this
Related